Evidence-Based Medicine Guidelines
Teriflunomide for multiple sclerosis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Teriflunomide for Multiple Sclerosis." Evidence-Based Medicine Guidelines, John Wiley & Sons, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/457724/all/Teriflunomide_for_multiple_sclerosis.
Teriflunomide for multiple sclerosis. Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. https://evidence.unboundmedicine.com/evidence/view/EBMG/457724/all/Teriflunomide_for_multiple_sclerosis. Accessed April 23, 2025.
Teriflunomide for multiple sclerosis. (2025). In Evidence-Based Medicine Guidelines. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/EBMG/457724/all/Teriflunomide_for_multiple_sclerosis
Teriflunomide for Multiple Sclerosis [Internet]. In: Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. [cited 2025 April 23]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/457724/all/Teriflunomide_for_multiple_sclerosis.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Teriflunomide for multiple sclerosis
ID - 457724
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/457724/all/Teriflunomide_for_multiple_sclerosis
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
